The Patent Finder

Rhizen Pharmaceuticals S.A.

Also on record
Records under this name other than the patents Rhizen Pharmaceuticals S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 21 patents it holds.

Back to Rhizen Pharmaceuticals S.A.

PatentTitleStatus Expires Confidence
US 10,072,013Novel Selective PI3K Delta Inhibitors
Lapsed on the fee record
Ended Sep 11, 2026 · High confidence
Lapsed on the fee recordEnded Sep 11, 2026High confidence
US 10,058,539Pharmaceutical Compositions Containing a PDE4 Inhibitor and a PI3 Delta or Dual PI3 Delta-Gamma Kinase Inhibitor
Lapsed on the fee record
Ended Aug 28, 2026 · High confidence
Lapsed on the fee recordEnded Aug 28, 2026High confidence
US 11,352,359PI3K protein kinase inhibitors
Lapsed on the fee record
Ended Jun 7, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jun 7, 2026From the USPTO record
US 9,969,740Forms of a PI3K delta selective inhibitor for use in pharmaceutical formulations
Lapsed on the fee record
Ended May 15, 2026 · From the USPTO record
Lapsed on the fee recordEnded May 15, 2026From the USPTO record
US 9,944,631Modulators of calcium release-activated calcium channel
Lapsed on the fee record
Ended Apr 17, 2026 · From the USPTO record
Lapsed on the fee recordEnded Apr 17, 2026From the USPTO record
US 9,815,8313,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases
Lapsed on the fee record
Ended Nov 14, 2025 · From the USPTO record
Lapsed on the fee recordEnded Nov 14, 2025From the USPTO record
US 9,783,533Glutaminase inhibitors
Lapsed on the fee record
Ended Oct 10, 2025 · From the USPTO record
Lapsed on the fee recordEnded Oct 10, 2025From the USPTO record
US 9,775,841Compounds as modulators of protein kinases
Lapsed on the fee record
Ended Oct 3, 2025 · From the USPTO record
Lapsed on the fee recordEnded Oct 3, 2025From the USPTO record
US 9,737,521Pharmaceutical Compositions Containing a PDE4 Inhibitor and a PI3 Delta or Dual PI3 Delta-Gamma Kinase Inhibitor
Lapsed on the fee record
Ended Aug 22, 2025 · High confidence
Lapsed on the fee recordEnded Aug 22, 2025High confidence
US 11,065,236Pharmaceutical Compositions Containing a PDE4 Inhibitor and a P13 Delta or Dual P13 Delta-Gamma Kinase Inhibitor
Lapsed on the fee record
Ended Jul 20, 2025 · High confidence
Lapsed on the fee recordEnded Jul 20, 2025High confidence
10 of 37 patents shown.
Pro members see all 37.
Pro members: see all 37 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited